Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center

BMC Urology

Volumn 13, Issue , 2013, Pages

  Hatakeyama, Shingo ^a   Yoneyama, Takahiro ^a   Hamano, Itsuto ^a   Murasawa, Hiromi ^a   Narita, Takuma ^a   Oikawa, Masaaki ^a   Hagiwara, Kazuhisa ^a   Noro, Daisuke ^a   Tanaka, Toshikazu ^a   Tanaka, Yoshimi ^a   Hashimoto, Yasuhiro ^a   Koie, Takuya ^a   Ohyama, Chikara ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Prognostic factors; Radical nephrectomy with thrombectomy; Renal cell carcinoma; Tumor thrombus

Indexed keywords

CHOLINESTERASE; SERUM ALBUMIN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; INFERIOR CAVA VEIN; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY VEIN; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OVERALL SURVIVAL; PROPENSITY SCORE; SURGICAL TECHNIQUE; SURGICAL THROMBECTOMY; THROMBUS;

CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; HUMANS; JAPAN; KIDNEY NEOPLASMS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEPHRECTOMY; PREVALENCE; PROGNOSIS; RENAL VEINS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THROMBECTOMY; TREATMENT OUTCOME; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 84885343273     PISSN: None     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-13-47     Document Type: Article

References (26)

1. Vein invasion in renal cell carcinoma: impact on metastatic behavior and survival. Ljungberg B, Stenling R, Osterdahl B, Farrelly E, Aberg T, Roos G, J Urol 1995 154 5 1681 1684 10.1016/S0022-5347(01)66749-1 7563321
2. Surgical approach to inferior vena caval extension of renal carcinoma. O'Donohoe MK, Flanagan F, Fitzpatrick JM, Smith JM, Brit J Urol 1987 60 6 492 496 10.1111/j.1464-410X.1987.tb05027.x 3427330 (Pubitemid 18002588)
3. Open surgery for localized RCC. Vander Eeckt K, Joniau S, Van Poppel H, Sci World J 2007 7 742 752
4. Vena caval involvement by renal cell carcinoma. Surgical resection provides meaningful long-term survival. Skinner DG, Pritchett TR, Lieskovsky G, Boyd SD, Stiles QR, Ann Surg 1989 210 3 387 392 discussion 392-384 10.1097/00000658-198909000-00014 2774709
5. Perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis. Bainbridge D, Martin J, Arango M, Cheng D, Lancet 2012 380 9847 1075 1081 10.1016/S0140- 6736(12)60990-8 22998717
6. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H, BJU Int 2004 94 1 33 41 10.1111/j.1464-410X.2004.04897.x 15217427 (Pubitemid 38980305)
7. Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome. Al Otaibi M, Abou Youssif T, Alkhaldi A, Sircar K, Kassouf W, Aprikian A, Mulder D, Tanguay S, BJU Int 2009 104 10 1467 1470 10.1111/j.1464-410X.2009.08575.x 19388993
8. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. Zisman A, Wieder JA, Pantuck AJ, Chao DH, Dorey F, Said JW, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS, J Urol 2003 169 3 909 916 10.1097/01.ju.0000045706.35470.1e 12576811 (Pubitemid 36188121)
9. Prognostic factors of renal cell carcinoma with extension into inferior vena cava. Tanaka M, Fujimoto K, Okajima E, Tanaka N, Yoshida K, Hirao Y, Int J Urol 2008 15 5 394 398 10.1111/j.1442-2042.2008.02017.x 18452454 (Pubitemid 351623890)
10. Prognostic significance of tumor extension into venous system in patients undergoing surgical treatment for renal cell carcinoma with venous tumor thrombus. Miyake H, Terakawa T, Furukawa J, Muramaki M, Fujisawa M, Eur J Surg Oncol 2012 38 7 630 636 10.1016/j.ejso.2012.03.006 22494774
11. The role of radical surgery for renal cell carcinoma with extension into the vena cava. Staehler G, Brkovic D, J Urol 2000 163 6 1671 1675 10.1016/S0022-5347(05)67517-9 10799157 (Pubitemid 30366710)
12. Surgical treatment of renal cancer with vena cava extension. Neves RJ, Zincke H, Brit J Urol 1987 59 5 390 395 10.1111/j.1464-410X.1987.tb04832.x 3594097 (Pubitemid 17070063)
13. Sobin LH, Gospodarowicz MK, Wittekind C, International Union against Cancer, TNM classification of malignant tumours Chichester, West Sussex, UK, Hoboken, NJ: Wiley-Blackwell 7 2010
14. Edge SB, American Joint Committee on Cancer, AJCC cancer staging manual New YorkLondon: Springer 7 2010
15. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP, Am J Clin Oncol 1982 5 6 649 655 10.1097/00000421-198212000-00014 7165009 (Pubitemid 13149996)
16. Downsizing a thrombus of advanced renal cell carcinoma in a presurgical setting with sorafenib. Takeda H, Nakano Y, Kashiwagi Y, Yoshino Y, Gotoh M, Urol Int 2012 88 2 235 237 10.1159/000334484 22179282
17. Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. Gettman MT, Boelter CW, Cheville JC, Zincke H, Bryant SC, Blute ML, J Urol 2003 169 4 1282 1286 10.1097/01.ju.0000049093.03392.cc 12629343 (Pubitemid 36323767)
18. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup. Haferkamp A, Bastian PJ, Jakobi H, Pritsch M, Pfitzenmaier J, Albers P, Hallscheidt P, Muller SC, Hohenfellner M, J Urol 2007 177 5 1703 1708 10.1016/j.juro.2007.01.039 17437789 (Pubitemid 46560667)
19. Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. Martinez-Salamanca JI, Huang WC, Millan I, Bertini R, Bianco FJ, Carballido JA, Ciancio G, Hernandez C, Herranz F, Haferkamp A, et al. Eur Urol 2011 59 1 120 127 10.1016/j.eururo.2010.10.001 20980095
20. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? Kim HL, Zisman A, Han KR, Figlin RA, Belldegrun AS, J Urol 2004 171 2 Pt 1 588 591 14713765 (Pubitemid 38090435)
21. Tumor thrombus of inferior vena cava in patients with renal cell carcinoma-clinical and oncological outcome of 50 patients after surgery. Vergho DC, Loeser A, Kocot A, Spahn M, Riedmiller H, BMC Res Notes 2012 5 5 10.1186/1756-0500-5-5
22. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus. Lambert EH, Pierorazio PM, Shabsigh A, Olsson CA, Benson MC, McKiernan JM, Urology 2007 69 6 1054 1058 10.1016/j.urology.2007.02.052 17572185 (Pubitemid 46891594)
23. Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib. Bex A, Van der Veldt AA, Blank C, Meijerink MR, Boven E, Haanen JB, Acta Oncol 2010 49 4 520 523 10.3109/02841860903521111 20105087
24. Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi. Karakiewicz PI, Suardi N, Jeldres C, Audet P, Ghosn P, Patard JJ, Perrotte P, Eur Urol 2008 53 4 845 848 10.1016/j.eururo. 2007.11.006 18053636 (Pubitemid 351273883)
25. Laparoscopic radical nephrectomy after shrinkage of a caval tumor thrombus with sunitinib. Harshman LC, Srinivas S, Kamaya A, Chung BI, Nat Rev Urol 2009 6 6 338 343 10.1038/nrurol.2009.84 19498412
26. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus. Cost NG, Delacroix SE Jr, Sleeper JP, Smith PJ, Youssef RF, Chapin BF, Karam JA, Culp S, Abel EJ, Brugarolas J, et al. Eur Urol 2011 59 6 912 918 10.1016/j.eururo.2011.02.032 21367518